A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

Clinical trial NCT07462377 · RECRUITING

Trial details

NCT number: NCT07462377
Sponsor: EpiBiologics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Epidermal Growth Factor Epidermal Growth Factor Receptor Epidermal Growth Factor Receptor Gene Mutation Non Small Cell Non Small Cell Lung Non Small Cell Lung Cancer Head and Neck Head and Neck Cancer Head and Neck Cancers Head and Neck Squamous Cell Cancer Head and Neck Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma HNSCC

Start date: 2026-03-31
Primary completion: 2029-07-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.